These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34881446)
21. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases. Allen J; Shears E; Powell J; Wojnarowska F Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011 [TBL] [Abstract][Full Text] [Related]
22. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen. Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455 [TBL] [Abstract][Full Text] [Related]
23. Bullous pemphigoid with prominent milium formation. Tsuruta D; Brzezinski P; Koga H; Ohata C; Furumura M; Hashimoto T Acta Dermatovenerol Croat; 2013; 21(1):35-8. PubMed ID: 23683484 [TBL] [Abstract][Full Text] [Related]
24. Coexistence of pemphigus and bullous pemphigoid. Matsubara K; Kanauchi H; Tanaka T; Imamura S J Dermatol; 1995 Jan; 22(1):68-71. PubMed ID: 7897029 [TBL] [Abstract][Full Text] [Related]
25. A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab. Bruni M; Moar A; Schena D; Girolomoni G Dermatol Online J; 2022 Mar; 28(2):. PubMed ID: 35670683 [TBL] [Abstract][Full Text] [Related]
26. Localized bullous pemphigoid: report of a case with an immunofluorescence and electron microscopical studies on the lesional distribution of 180-KD bullous pemphigoid antigen, beta 4 integrin, and type VII collagen. Kitajima Y; Suzuki M; Johkura Y; Yaoita H J Dermatol; 1993 Jul; 20(7):406-12. PubMed ID: 8408921 [TBL] [Abstract][Full Text] [Related]
27. [Anti-p200 pemphigoid: a spectacular response to dapsone]. Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034 [TBL] [Abstract][Full Text] [Related]
28. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid. Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657 [TBL] [Abstract][Full Text] [Related]
29. Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid. Chan YC; Sun YJ; Ng PP; Tan SH Clin Exp Dermatol; 2003 Nov; 28(6):651-6. PubMed ID: 14616835 [TBL] [Abstract][Full Text] [Related]
31. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144 [TBL] [Abstract][Full Text] [Related]
32. Case with Brunsting-Perry-like localized subepidermal blister formations and immunoglobulin G antibodies against unidentified basement membrane zone antigen. Sato-Shibuya M; Dainichi T; Egawa G; Honda T; Otsuka A; Ishii N; Hashimoto T; Miyachi Y; Kabashima K J Dermatol; 2016 Apr; 43(4):426-8. PubMed ID: 26362108 [TBL] [Abstract][Full Text] [Related]
34. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid? Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339 [TBL] [Abstract][Full Text] [Related]
35. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070 [TBL] [Abstract][Full Text] [Related]
36. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. Lazarova Z; Yancey KB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276 [TBL] [Abstract][Full Text] [Related]
37. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734 [TBL] [Abstract][Full Text] [Related]
38. Localized bullous pemphigoid: a case report. Wang Y; Mao X; Liu Y; Li L Ann Transl Med; 2020 Mar; 8(5):249. PubMed ID: 32309396 [TBL] [Abstract][Full Text] [Related]
39. Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid. Hirano Y; Iwata H; Tsujuwaki M; Mai S; Mai Y; Imafuku K; Izumi K; Koga H; Ujiie H J Dermatol; 2022 Mar; 49(3):374-378. PubMed ID: 34845743 [TBL] [Abstract][Full Text] [Related]
40. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results. Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]